dSarm/Sarm1 is required for activation of an injury-induced axon death pathway
Osterloh, Jeannette M. ; Yang, Jing ; Rooney, Timothy M. ; Fox, A. Nicole ; Adalbert, Robert ; Powell, Eric H. ; Sheehan, Amy E. ; Avery, Michelle A. ; Hackett, Rachel ; Logan, Mary A. ... show 10 more
Citations
Authors
Yang, Jing
Rooney, Timothy M.
Fox, A. Nicole
Adalbert, Robert
Powell, Eric H.
Sheehan, Amy E.
Avery, Michelle A.
Hackett, Rachel
Logan, Mary A.
MacDonald, Jennifer M.
Ziegenfuss, Jennifer S.
Milde, Stefan
Hou, Ying-Ju
Nathan, Carl
Ding, Aihao
Brown, Robert H. Jr.
Comforti, Laura
Coleman, Michael
Tessier-Lavigne, Marc
Zuchner, Stephan
Freeman, Marc R.
Student Authors
Timothy Rooney
Michelle Avery
Jennifer MacDonald
Jennifer Zeigenfuss
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Keywords
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
Axonal and synaptic degeneration is a hallmark of peripheral neuropathy, brain injury, and neurodegenerative disease. Axonal degeneration has been proposed to be mediated by an active autodestruction program, akin to apoptotic cell death; however, loss-of-function mutations capable of potently blocking axon self-destruction have not been described. Here, we show that loss of the Drosophila Toll receptor adaptor dSarm (sterile alpha/Armadillo/Toll-Interleukin receptor homology domain protein) cell-autonomously suppresses Wallerian degeneration for weeks after axotomy. Severed mouse Sarm1 null axons exhibit remarkable long-term survival both in vivo and in vitro, indicating that Sarm1 prodegenerative signaling is conserved in mammals. Our results provide direct evidence that axons actively promote their own destruction after injury and identify dSarm/Sarm1 as a member of an ancient axon death signaling pathway.
Source
Science. 2012 Jul 27;337(6093):481-4. Epub 2012 Jun 7. Link to article on publisher's site